CRISPR-focused Excision BioTherapeutics Strengthens Board of Directors Appointing Veteran Pharmaceutical Executive Bill Carson, M.D.

    NEXT STORY
    RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia
    PREV STORY
    River Oaks Treatment Center Now Offering Addiction Track For First Responders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Calithera Biosciences Reports Fourth Quarter 2018 Financial Results and Recent Highlights

    author_avatar
    NASDAQ Market News

    Translate Bio Announces Second Quarter 2019 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference

    author_avatar
    NASDAQ Market News